Related Experiment Video
Updated: Mar 16, 2026

Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm
Published on: June 7, 2018
[Counterfeit Medicines in Internet and the Fakeshare European Project: Experiences and Activities in Spain]
Daniel Catalán-Matamoros1, Nuria González-Ochando2, Henar Pecharroman-Arribas2
1Departamento de Inspección y Control, Agencia Española de Medicamentos y Productos Sanitarios. Ministerio de Sanidad, Servicios Sociales e Igualdad and Departamento de Periodismo y Comunicación Audiovisual. Universidad Carlos III de Madrid.
Abstract:
The illicit trafficking of medicines over the Internet is a growing problem that affects public health. Since 2013, the Spanish Agency of Medicines and Medical Devices (AEMPS) participates in the European project Fakeshare, co-funded by the European Commission and coordinated by the Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA). This project aims to coordinate initiatives against the illegal supply of medicines, including from purchases through websites engaged in illegal activity, to thefts and other diversions of medicines to the illicit trafficking.This paper presents the activities in that area as well as strategies and elaborated materials at the national level. The keys to fight or face the illegal sale of medicines over the internet are coordinated cooperation with all the stakeholders, development of communication campaigns to raise awareness and sensitize consumers, health professionals and industry organizations about the risks of buying medicines on illegal websites, creating databases to share information on thefts and other deviations to the illegal market and disseminate national practices to combat illicit medicines trafficking at European and international levels.
Related Concept Videos
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Drug Control Governance: Regulatory Bodies and Their Impact
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Products: Biologics, Biosimilars and Interchangeables
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Bioequivalence studies: Biowaivers

